Christopher J. Kane - Concepedia

Author

Christopher J. Kane

University of California San Diego ORCID

Also Known As

Amling, Christopher L., C J Kane, C Kane, C. Ibechukwu Kane, C. J. Kane, C. Kane, C.J Kane, C.J. Kane, CHRISTOPHER J. KANE, CHRISTOPHER KANE

740

Publications

25.7K

Citations

H-Index

174

Concepts

All Affiliations

University of California San Diego University of California, Los Angeles University of California, San Francisco Augusta University Duke University

About

Christopher J. Kane is an author at University of California San Diego specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	93	11.5K
2	Health Sciences	15	16	1.4K
3	Public Health	14	17	1.4K
4	Engineering	10	10	375
5	Natural Sciences	1	1	12

Christopher J. Kane

267

Publications

23.4K

Citations

H-Index

Page 1

	Year	Citations
The Molecular Taxonomy of Primary Prostate Cancer Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Cell UrologyGenitourinary CancerMedicinePathologyPrimary Prostate Cancer	2015	3.1K
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, Journal of the National Comprehensive Cancer Network UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2019	1.5K
Prostate Cancer, Version 1.2016 James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Journal of the National Comprehensive Cancer Network UrologySurgical OncologyCancer EpidemiologyHealth PolicyGenitourinary Cancer	2016	650
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial Naomi B. Haas, Judith Manola, Robert G. Uzzo, The Lancet UrologyGenitourinary CancerMedicinePharmacologyClinical Trials	2016	625
Renal cell cancer stage migration Christopher J. Kane, Katherine Mallin, Jamie Ritchey, Cancer	2008	588
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy Shabnam Shalapour, Joan Font-Burgada, Giuseppe Di, Nature T-regulatory CellImmunologyImmunosuppressive Plasma CellsAutoimmunityImmunotherapy	2015	576
TIME TO STONE PASSAGE FOR OBSERVED URETERAL CALCULI: A GUIDE FOR PATIENT EDUCATION O. Fred Miller, Christopher J. Kane The Journal of Urology	1999	466
Saw Palmetto for Benign Prostatic Hyperplasia Stephen Bent, Christopher J. Kane, Katsuto Shinohara, New England Journal of Medicine	2006	401
Active surveillance for the management of prostate cancer in a contemporary cohort Marc Dall’Era, Badrinath R. Konety, Janet E. Cowan, Cancer	2008	400
Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality Robert T. Dess, Holly Hartman, Brandon A. Mahal, JAMA Oncology	2019	398

Page 1